Your browser doesn't support javascript.
loading
The combined efficacy of OTS964 and temozolomide for reducing the size of power-law coded heterogeneous glioma stem cell populations.
Sugimori, Michiya; Hayakawa, Yumiko; Tamura, Ryoi; Kuroda, Satoshi.
Afiliação
  • Sugimori M; Department of Integrative Neuroscience, University of Toyama, Toyama, Toyama 930-0194, Japan.
  • Hayakawa Y; Department of Neurosurgery, University of Toyama, Toyama, Toyama 930-0194, Japan.
  • Tamura R; Department of Integrative Neuroscience, University of Toyama, Toyama, Toyama 930-0194, Japan.
  • Kuroda S; Department of Neurosurgery, University of Toyama, Toyama, Toyama 930-0194, Japan.
Oncotarget ; 10(24): 2397-2415, 2019 Mar 22.
Article em En | MEDLINE | ID: mdl-31040930
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão